Stephens Inc Catalyst Biosciences, Inc. Transaction History

Stephens Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$0.49 - $1.95 $7,477 - $29,757	-15,260 Reduced 41.48%	21,525 $11,000
Q2 2022 Aug 03, 2022	SELL	$0.36 - $1.78 $153 - $756	-425 Reduced 1.14%	36,785 $65,000
Q1 2022 May 04, 2022	BUY	$0.51 - $1.0 $4,092 - $8,025	8,025 Added 27.5%	37,210 $25,000
Q4 2021 Mar 07, 2022	BUY	$0.91 - $4.16 $11,238 - $51,376	12,350 Added 73.36%	29,185 $27,000
Q3 2021 Oct 27, 2021	SELL	$3.78 - $5.18 $189 - $259	-50 Reduced 0.3%	16,835 $69,000
Q2 2021 Aug 12, 2021	BUY	$4.1 - $5.33 $27,162 - $35,311	6,625 Added 64.57%	16,885 $73,000
Q1 2021 May 14, 2021	BUY	$4.93 - $7.15 $50,581 - $73,359	10,260 New	10,260 $52,000
Q4 2020 Feb 10, 2021	SELL	$4.55 - $7.29 $56,420 - $90,396	-12,400 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$4.22 - $6.04 $52,328 - $74,896	12,400 New	12,400 $53,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

Stay updated on Stephens Inc with notifications on news.